William (Bill) Jackson
VP Regulatory, Clinical, and Compliance
William (Bill) Jackson has been the Vice President of Regulatory, Clinical, and Compliance for Colorado Therapeutics since the company was formed in 2015. He has over 30 years of regulatory, clinical, and compliance experience. He is also the current Vice President of Regulatory, Clinical, and Compliance for Colibri Heart Valve LLC, a position he has held since April of 2015. Prior to joining Colibri, Bill has served as president of W.F. Jackson Associates, Ltd., a successful practice he founded to provide regulatory, quality and clinical consulting services to domestic and international medical device companies. Previous to this, Bill held senior management positions at a variety of medical device companies including Intermedics, Neuromed, Genetic Labs (porcine), St. Jude Medical, TranS1, MiMedix, and Optovue. During his tenure at St. Jude, Bill worked on the committee that created the first two directives that outlined the essential requirements and classification rules for the assessment of medical devices (MDD) and active implantable medical devices (AIMD). Before joining industry, Bill conducted cardiology research and developed clinical trial protocols for the department of cardiology at the University of North Dakota, School of Medicine. During his career, Bill has prepared and lead over 400 regulatory submissions to more than 75 countries (European Economic Area, Pan Pacific countries, and the Americas). Bill received a Bachelor of Arts in zoology and minors in chemistry and physiological psychology from Concordia College and a Master of Business Administration from the University of Minnesota (Moorhead).